TSX:WLLW - Toronto Stock Exchange - CA97111B4047 - Common Stock - Currency: CAD
TSX:WLLW (7/17/2025, 7:00:00 PM)
0.23
-0.02 (-8%)
The current stock price of WLLW.CA is 0.23 CAD. In the past month the price decreased by -69.33%. In the past year, price decreased by -91.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 330.89M | ||
EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 267.18M | ||
EDT.CA | SPECTRAL MEDICAL INC | N/A | 231.27M | ||
TH.CA | THERATECHNOLOGIES INC | N/A | 198.63M | ||
ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 158.10M | ||
HBP.CA | HELIX BIOPHARMA CORP | N/A | 74.16M | ||
MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 73.37M | ||
COV.CA | COVALON TECHNOLOGIES LTD | 19.92 | 71.02M | ||
MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 58.20M | ||
BLU.CA | BLUENERGIES LTD | N/A | 55.79M | ||
SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 41.96M | ||
MBX.CA | MICROBIX BIOSYSTEMS INC | 29.5 | 41.47M |
Willow Biosciences, Inc. is a biotechnology company, which engages in the research, development, and commercialization of plant derived ingredients for consumer care, food and beverage, and pharmaceutical products. The company is headquartered in Calgary, Alberta and currently employs 19 full-time employees. The company went IPO on 2017-09-14. The firm develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. The company also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. The company is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.
WILLOW BIOSCIENCES INC
202, 1201 5th Street SW
Calgary ALBERTA T2L 1Y8 CA
CEO: Trevor Peters
Employees: 19
Phone: 14039105140
The current stock price of WLLW.CA is 0.23 CAD. The price decreased by -8% in the last trading session.
The exchange symbol of WILLOW BIOSCIENCES INC is WLLW and it is listed on the Toronto Stock Exchange exchange.
WLLW.CA stock is listed on the Toronto Stock Exchange exchange.
WILLOW BIOSCIENCES INC (WLLW.CA) has a market capitalization of 144.77M CAD. This makes WLLW.CA a Micro Cap stock.
WILLOW BIOSCIENCES INC (WLLW.CA) currently has 19 employees.
WILLOW BIOSCIENCES INC (WLLW.CA) has a support level at 0.21. Check the full technical report for a detailed analysis of WLLW.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
WLLW.CA does not pay a dividend.
WILLOW BIOSCIENCES INC (WLLW.CA) will report earnings on 2025-08-11.
WILLOW BIOSCIENCES INC (WLLW.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
ChartMill assigns a fundamental rating of 1 / 10 to WLLW.CA. WLLW.CA may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months WLLW.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 65.35% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -179.33% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to WLLW.CA. The Buy consensus is the average rating of analysts ratings from 7 analysts.